Leading GMP cell CDMO I Peace, Inc., specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the number of GMP-grade iPS cells manufactured has reached 100 lines. This achievement solidifies I Peace as a true leader in the realm of iPS cell manufacturers, equipped with abundant experience in manufacturing GMP-grade iPS cells in compliance with global regulations.

I Peace has manufactured a variety of iPS cells, including off-the-shelf master cell stock, HLA super-donor iPS cells that can cover a large portion of the U.S. population, specific iPS cells for CDMO service, and iPS cells for our personal iPS cell banking service. These cells are manufactured in a facility that complies with regulations of the U.S., Japan, and EU. I Peace is also capable of providing quality assurance according to the regulatory guidelines of the U.S., Japan, EU, or ISO 17025.  

Since its inception in 2015, I Peace has been working on the development of mass iPS cell manufacturing technology while engaging in the development of the iPS cell market, resulting in the cumulative manufacturing of 100 iPS cell lines today.

I Peace will continue to serve pharmaceutical companies and cell therapy developers by providing iPS cells and CDMO services and will contribute to the development and democratization of iPS cell-derived therapies.